ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral ...

The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...

"MTPA’s Radicava shows long-term benefit in ALS trials" was originally created and published by Clinical Trials Arena, a ...

Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS drug NUZ-001.

By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...

Robin Leaper lost her voice to ALS. Artificial Intelligence has given her back the ability to speak with her own voice.

Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...

A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...

A new brain-computer interface can decode a person's inner speech, which could help people with paralysis communicate.

• Key Amyotrophic Lateral Sclerosis Pipeline Therapies: ION363, FB418, SRK-015, RNS60, QRL-201, SAR443820, MN-166, VM202, VRG-50635, Zilucoplan, and others.